FDA Proposes Voluntary Consensus Standards to Help Speed Drug Reviews

Drug GMP Report
A A
CDER released draft guidance on a proposal to create voluntary consensus standards for drug quality that would help boost innovation and speed up drug reviews.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00